Filing step-change
BIOGEN · 2026-10
Quarterly observations that moved versus the prior period in 2026-10. Facts only — not a call to act.
Narrative date 2026-10-21 · Evidence medium
BIOGEN's Gross Margin accelerated to 100%, up from 49.93% in the last quarter.
Raw Evidence
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 100 % | 49.93 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 49.93 % | -18.09 | ▲ |
Cite this
Source: Samhati filing step-change for BIOGEN (2026-10). Observation: BIOGEN's Gross Margin accelerated to 100%, up from 49.93% in the last quarter. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/biogen/q/2026-10
Other periods